yes, i do believe it will be worth it eventually - the molecule has tremendous value, we just had a terrible leader over nearly all of my investment period. Then we finally get a great one, and the poor guy is on medical leave. go figure.

i will say i have learned a couple of things. First, i won't ever buy another stock on the OTC. it's been disappointing to see how many lowlifes there are out there spewing negativity just to short a stock - the whole OTC is a big cesspool.

and my second lesson is to never own stock in a company that depends on the FDA for an approval - because there is no rhyme or reason to how they approach things. the fact that they support a company like Purdue (like someone on here mentioned) and yet jerk us around on a drug that will save so many lives is disgusting.

i do think something breaks big for us in 2023 - hopefully sooner rather than later - we need Cyrus back at the helm, and we need this $%&$ hold lifted already.